Atovaquone is an antibiotic drug used to treat malaria, a serious and common parasitic infection spread by mosquito bites. It works by preventing the parasite from producing energy and is used in combination with proguanil to effectively treat malaria. Atovaquone is a better option than older drugs such as chloroquine due to its increased efficacy, lower cost and safety profile. It is commonly used as a prophylactic treatment to prevent infections in travelers to areas with a high risk of malaria infection. It is a preferred treatment for HIV-positive individuals, who have a higher risk of developing severe malaria due to their weakened immune systems.

From: International Journal of Anesthesia

Related Article For "Atovaquone"

About (1) results

Editor: Vipin Arora,  Department of Anesthesia, Critical Care and Pain Medicine, Harvard Medical School & Massachusetts General Hospital                                     
Publication Type: Open Access Journal
Description: International Journal of Anesthesia covers a wide selection of areas relevant to scientific and clinical content of anesthesiology field. IJAN aims to add real international flavor to anesthetic studies pertaining to all possible forms and to advance the understanding and application of novel techniques.